Timing, Management, and Outcomes of Liver Transplantation in Primary Sclerosing Cholangitis
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Primary sclerosing cholangitis (PSC) is a chronic, immune-mediated cholestatic liver disease that often progresses to secondary biliary cirrhosis and end-stage liver disease. Short of liver transplantation (LT), there is no effective treatment for PSC. PSC accounts for approximately 5% of total adult LTs in the US and is currently the fifth most common indication for LT. Patient and graft survival for PSC is among the highest for all indications for LT. The main factors that impact outcomes after LT for PSC include biliary strictures, rejection, and recurrence of PSC. Recurrent PSC (rPSC) develops in 20% of LT recipients within 5 years of LT and is associated with negative patient and graft survival. LT is a viable option for recipients who develop rPSC and progress to graft failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Altogether, PSC represents 4-5% of the total liver transplants performed in Europe and North America, 390,391 with higher rates reported in the Nordic countries.392”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [390]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 100 · Cited by 46
Metadata
- Authors
- Levy, C., & Martin, E.
- Affiliations
- University of Miami (US)
- ORCID
- Levy, Cynthia
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 2017-11
- Volume
- 37
- Issue
- 04
- Pages
- 305-313
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2781003852
- Cited by
- 46
- References
- 100
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 7 · 2023: 8 · 2022: 5 · 2021: 5 · 2020: 3 · 2019: 5 · 2018: 5
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- primary sclerosing cholangitis, liver transplantation, biliary strictures, graft rejection, graft survival, patient survival, end-stage liver disease, biliary cirrhosis
- MeSH terms
- Graft Rejection, Graft Survival, Humans, Recurrence, Risk Factors, Time Factors, Tissue Donors, Waiting Lists, Cholangitis, Sclerosing, Liver Transplantation, Treatment Outcome, Disease Progression, End Stage Liver Disease, Time-to-Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Timing, Management, and Outcomes of Liver Transplantation in Primary Sclerosing Cholangitis. https://app.cochat.ai/papers/10.1055/s-0037-1608655
- The paper
- Levy, C., & Martin, E. (2017). Timing, Management, and Outcomes of Liver Transplantation in Primary Sclerosing Cholangitis. Seminars in Liver Disease. https://doi.org/10.1055/s-0037-1608655
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.